Your browser doesn't support javascript.
loading
Trastuzumab (Herceptin®): overcoming resistance in HER2-overexpressing breast cancer models.
Albrecht, Huguette.
  • Albrecht H; University of California at Davis School of Medicine, Department of Public Health Sciences, Sacramento, CA, USA. huguette.albrecht@ucdmc.ucdavis.edu
Immunotherapy ; 2(6): 795-8, 2010 Nov.
Article en En | MEDLINE | ID: mdl-21091112
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2010 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2010 Tipo del documento: Article